Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity

por Zheng, Quan, Tang, Jiajia, Aicher, Alexandra, Bou Kheir, Tony, Sabanovic, Berina, Ananthanarayanan, Preeta, Reina, Chiara, Chen, Minchun, Gu, Jian-Min, He, Bin, Alcala, Sonia, Behrens, Diana, Lawlo, Rita T., Scarpa, Aldo, Hidalgo, Manuel, Sainz, Bruno, Sancho, Patricia, Heeschen, Christopher
Publicado 2023